217 related articles for article (PubMed ID: 23287431)
21. Cerebrospinal fluid (CSF) cytology: current status and diagnostic applications.
Bigner SH
J Neuropathol Exp Neurol; 1992 May; 51(3):235-45. PubMed ID: 1583530
[TBL] [Abstract][Full Text] [Related]
22. [Ferritin in the cerebrospinal fluid as an early indicator of neuromeningeal involvement in patients with malignant lymphoma].
Aviles A; Gómez R; Salas J
Gac Med Mex; 1991; 127(3):249-52. PubMed ID: 1800218
[TBL] [Abstract][Full Text] [Related]
23. [Determination of S-100 beta protein in cerebrospinal fluid of patients with metastatic carcinoma to central nervous system].
Zhao G; Yang Y; Su X
Zhonghua Nei Ke Za Zhi; 2000 Nov; 39(11):732-4. PubMed ID: 11798531
[TBL] [Abstract][Full Text] [Related]
24. Detection of malignant haematopoietic cells in the cerebrospinal fluid by conventional cytology and flow cytometry.
Nückel H; Novotny JR; Noppeney R; Savidou I; Dührsen U
Clin Lab Haematol; 2006 Feb; 28(1):22-9. PubMed ID: 16430456
[TBL] [Abstract][Full Text] [Related]
25. Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.
Broussalis E; Hutterer M; Oppermann K; Wipfler P; Pilz G; Harrer A; Haschke-Becher E; Golaszewski S; Schönauer U; Weis S; Killer-Oberpfalzer M; Mc Coy M; Trinka E; Kraus J
Acta Neurol Scand; 2012 Sep; 126(3):e11-6. PubMed ID: 22211863
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometry and cytomorphology evaluation of hematologic malignancy in cerebrospinal fluids: comparison with retrospective clinical outcome.
Cesana C; Klersy C; Scarpati B; Brando B; Faleri M; Bertani G; Gatti A; Volpato E; Barba C; Ferri U; Scampini L; Grillo G; Lando G; Nosari A; Morra E; Cairoli R
Ann Hematol; 2011 Jul; 90(7):827-35. PubMed ID: 21212952
[TBL] [Abstract][Full Text] [Related]
27. To protect and defend: central nervous system prophylaxis in patients with non-Hodgkin's lymphoma.
Lim HY; Thiel E; Glantz MJ
Curr Opin Oncol; 2008 Sep; 20(5):495-501. PubMed ID: 19106650
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.
Bench AJ; Erber WN; Scott MA
Clin Lab Haematol; 2005 Jun; 27(3):148-71. PubMed ID: 15938721
[TBL] [Abstract][Full Text] [Related]
29. [Importance of urgent cerebrospinal fluid examination for early diagnosis of central nervous system infections].
Kelbich P; Koudelková M; Machová H; Tomaskovic M; Vachata P; Kotalíková P; Chmelíková V; Hanuljaková E
Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):9-20. PubMed ID: 17417750
[TBL] [Abstract][Full Text] [Related]
30. The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons.
Corcoran C; Rebe K; van der Plas H; Myer L; Hardie DR
J Clin Virol; 2008 Aug; 42(4):433-6. PubMed ID: 18455472
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the Utility of Cytology and Flow Cytometry of Cerebrospinal Fluid Samples in Clinical Practice.
Nam AS; Giorgadze T; Tam W; Chadburn A
Acta Cytol; 2018; 62(2):130-136. PubMed ID: 29510385
[TBL] [Abstract][Full Text] [Related]
32. Modern cerebrospinal fluid analyses for the diagnosis of diffuse large B-cell lymphoma of the CNS.
Baraniskin A; Schroers R
CNS Oncol; 2014 Jan; 3(1):77-85. PubMed ID: 25054902
[TBL] [Abstract][Full Text] [Related]
33. [Flow cytometry: application for the diagnosis and the follow-up of hematological malignancies].
Drénou B; Fardel O; Fauchet R; Amiot L
Ann Biol Clin (Paris); 2002; 60(6):663-72. PubMed ID: 12446230
[TBL] [Abstract][Full Text] [Related]
34. Lymphoid and myeloid neoplasms involving cerebrospinal fluid: comparison of morphologic examination and immunophenotyping by flow cytometry.
Roma AA; Garcia A; Avagnina A; Rescia C; Elsner B
Diagn Cytopathol; 2002 Nov; 27(5):271-5. PubMed ID: 12411991
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal Fluid Flow Cytometry: Utility in Central Nervous System Lymphoma Diagnosis.
Au KLK; Latonas S; Shameli A; Auer I; Hahn C
Can J Neurol Sci; 2020 May; 47(3):382-388. PubMed ID: 32228724
[TBL] [Abstract][Full Text] [Related]
36. Flowcytometric evaluation of cerebrospinal fluid in childhood ALL identifies CNS involvement better then conventional cytomorphology.
de Haas V; Pieters R; van der Sluijs-Gelling AJ; Zwaan CM; de Groot-Kruseman HA; Sonneveld E; Stigter RL; van der Velden VHJ
Leukemia; 2021 Jun; 35(6):1773-1776. PubMed ID: 32855440
[No Abstract] [Full Text] [Related]
37. Cerebrospinal fluid cytological and biochemical characteristics in the presence of CNS neoplasia.
Almeida SM; Nanakanishi E; Conto AJ; Souza LP; Antonelli Filho D; Roda CD
Arq Neuropsiquiatr; 2007 Sep; 65(3B):802-9. PubMed ID: 17952285
[TBL] [Abstract][Full Text] [Related]
38. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
Drusco A; Bottoni A; Laganà A; Acunzo M; Fassan M; Cascione L; Antenucci A; Kumchala P; Vicentini C; Gardiman MP; Alder H; Carosi MA; Ammirati M; Gherardi S; Luscrì M; Carapella C; Zanesi N; Croce CM
Oncotarget; 2015 Aug; 6(25):20829-39. PubMed ID: 26246487
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer.
Bach F; Bjerregaard B; Sölétormos G; Bach FW; Horn T
Cancer; 1993 Oct; 72(8):2376-82. PubMed ID: 8402452
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of leptomeningeal disease in diffuse large B-cell lymphomas of the central nervous system by flow cytometry and cytopathology.
Schroers R; Baraniskin A; Heute C; Vorgerd M; Brunn A; Kuhnhenn J; Kowoll A; Alekseyev A; Schmiegel W; Schlegel U; Deckert M; Pels H
Eur J Haematol; 2010 Dec; 85(6):520-8. PubMed ID: 20727005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
